Shanghai Medicilon Inc
SSE:688202
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Shanghai Medicilon Inc (688202) under the Base Case is 57.95 CNY per share.
Compared with the current market price of 74.52 CNY, the stock appears
Overvalued by 22% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Shanghai Medicilon Does
Shanghai Medicilon Inc. is a drug research and development services company. It helps pharmaceutical and biotech clients move new medicines from early discovery into preclinical testing by running chemistry, biology, pharmacology, drug metabolism, and safety studies. In plain terms, it is a research partner that does much of the lab work needed before a drug candidate can enter human trials.
- Headquarters
- China CN
- Employees
- 2 440
- IPO date
- Nov 5, 2019
Continue Research
Decided on Shanghai Medicilon? Get an email when Shanghai Medicilon Inc reaches the price you’d buy at. Free with an account.
What is the Intrinsic Value of one Shanghai Medicilon Inc stock?
The intrinsic value for
Shanghai Medicilon Inc (688202) under the Base Case is 57.95 CNY.
Is Shanghai Medicilon Inc stock undervalued or overvalued?
Compared with the current market price of 74.52 CNY, the stock appears Overvalued by 22% .